期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
Measuring luminal esophageal temperature during pulmonary vein isolation of atrial fibrillation
1
作者 Daisuke Sato Kunihiro Teramoto +6 位作者 Hiroki Kitajima Naoto Nishina Yoshitomi Kida Hiroki Mani Masahiro Esato Yeong-Hwa Chun toshiji iwasaka 《World Journal of Cardiology》 CAS 2012年第5期188-194,共7页
AIM:To investigate the luminal esophageal temperature(LET) at the time of delivery of energy for pulmonary vein isolation(PVI).METHODS:This study included a total of 110 patients with atrial fibrillation who underwent... AIM:To investigate the luminal esophageal temperature(LET) at the time of delivery of energy for pulmonary vein isolation(PVI).METHODS:This study included a total of 110 patients with atrial fibrillation who underwent their first PVI procedure in our laboratory between March 2010 and February 2011.The LET was monitored in all patients.We measured the number of times that LET reached the cut-off temperature,the time when LET reached the cut-off temperature,the maximum temperature(T max) of the LET,and the time to return to the original preenergy delivery temperature once the delivery of energy was stopped.RESULTS:Seventy-eight patients reached the cut-off temperature.It took 6 s at the shortest time for the LET to reach the cut-off temperature,and 216.5 ± 102.9 s for the temperature to return to the level before the de-livery of energy.Some patients experienced a transient drop in the LET(TDLET) just before energy delivery.Ablation at these sites always produced a rise to the LET cut-off temperature.TDLET was not observed at sites where the LET did not rise.Thus,the TDLET before the energy delivery was useful to distinguish a high risk of esophageal injury before delivery of energy.CONCLUSION:Sites with a TDLET before energy delivery should be ablated with great caution or,perhaps,not at all. 展开更多
关键词 RADIOFREQUENCY CATHETER ablation Atrioesophageal FISTULA ESOPHAGEAL injury Real time LUMINAL ESOPHAGEAL TEMPERATURE monitoring Open irrigation
下载PDF
地区性的动脉的僵硬上的 eicosapentaenoic 酸的效果: 由织物 Doppler 成像的评价
2
作者 Mio Haiden Yoko Miyasaka +5 位作者 Yutaka Kimura Satoshi Tsujimoto Hirofumi Maeba Yoshinobu Suwa toshiji iwasaka Ichiro Shiojima 《World Journal of Cardiology》 CAS 2012年第8期256-259,共4页
AIM:To evaluate the effects of eicosapentaenoic acid(EPA) on regional arterial stiffness assessed by strain rate using tissue Doppler imaging.METHODS:Nineteen eligible patients were prospectively studied(mean age 62 &... AIM:To evaluate the effects of eicosapentaenoic acid(EPA) on regional arterial stiffness assessed by strain rate using tissue Doppler imaging.METHODS:Nineteen eligible patients were prospectively studied(mean age 62 ± 8 years,68% men).Subjects with large vessel complications and/or diabetes mellitus were excluded.The strain rate of the ascending aorta was measured by tissue Doppler imaging as an index of regional arterial stiffness,and brachialankle pulse wave velocity(baPWV) was measured as an index of degree of systemic arteriosclerosis.These indices were compared before and after administration of EPA at 1800 mg/d for one year.RESULTS:The plasma concentration of EPA increased significantly after EPA administration(3.0% ± 1.1% to 8.5% ± 2.9%,P 【 0.001).There were no significant changes in baPWV(1765 ± 335 cm/s to 1745 ± 374 cm/s),low-density lipoprotein cholesterol levels(114 ± 29 mg/dL to 108 ± 28 mg/dL),or systolic blood pressure(131 ± 16 mmHg to 130 ± 13 mmHg) before and after EPA administration.In contrast,the strain rate was significantly increased by administration of EPA(19.2 ± 5.6 s-1,23.0 ± 6.6 s-1,P 【 0.05).CONCLUSION:One year of administration of EPA resulted in an improvement in regional arterial stiffness which was independent of blood pressure or serum cholesterol levels. 展开更多
关键词 ECHOCARDIOGRAPHY TISSUE DOPPLER imaging Strain rate ARTERIAL STIFFNESS Eicosapentaenoic acid
下载PDF
尼可地尔经皮冠状动脉介入治疗(PCI)降低心肌损伤 被引量:3
3
作者 Tsuyoshi Isono Hiroshi Kamihata +9 位作者 Yasuo Sutani Masayuki Motohiro Satoshi Yamamoto Shiori Kyoui Yoshiji Iharada Kouji Kurimoto Katsuko Hara Hakuo Takahashi toshiji iwasaka 陈浩 《首都食品与医药》 2016年第20期104-104,共1页
背景尼可地尔作为辅助治疗药物,在缺血性心脏病患者的治疗中具有良好效果。本研究旨在评估尼可地尔选择性经皮冠状动脉治疗(PCI)后对心肌的保护作用。方法我们随机地将49个接受选择性PCI治疗的病人分为尼可地尔及对照这两组。PCI治疗前... 背景尼可地尔作为辅助治疗药物,在缺血性心脏病患者的治疗中具有良好效果。本研究旨在评估尼可地尔选择性经皮冠状动脉治疗(PCI)后对心肌的保护作用。方法我们随机地将49个接受选择性PCI治疗的病人分为尼可地尔及对照这两组。PCI治疗前,尼可地尔组先静脉推注4mg尼可地尔,介入治疗后再以6mg每小时的量静脉滴注24小时。口服尼可地尔给药组持续给药直至接下来的冠状动脉造影(CAG)。PCI治疗前及PCI治疗后0、4、24及48小时分别采集各组静脉血样,检测肌酸激酶(CK)、肌酸激酶MB亚型(CK-MB)、肌钙蛋白Ⅰ(TnI)和肌红蛋白的量。通过对比治疗前后的脑室造影来评价左心室功能及左心室壁运动。结果 PCI治疗后24小时,尼可地尔组的心肌酶水平显著低于对照组;实验组及对照组的CK分别为78.1±34.9,117.4±137.9U/l,显著性P=0.0141,CK-MB为1.57±1.90,2.67±4.50U/l,显著性P=0.0485,TnI为0.37±0.55,0.86±1.65ng/ml,显著性P=0.0101。尼可地尔组的局部左心室壁运动在后期较对照组显著增强。结论尼可地尔能抑制选择性PCI治疗后心肌酶的水平,并在后期显著增强左心室壁的运动,表明尼可地尔可提高PCI治疗时对心肌的保护,降低因血管成形术造成的心肌损伤。 展开更多
关键词 尼可地尔 介入治疗(PCI) 心肌损伤
原文传递
尼可地尔经皮冠状动脉介入治疗(PCI)降低心肌损伤
4
作者 Tsuyoshi Isono Hiroshi Kamihata +9 位作者 Yasuo Sutani Masayuki Motohiro Satoshi Yamamoto Shiori Kyoui Yoshiji Iharada Kouji Kurimoto Katsuko Hara Hakuo Takahashi toshiji iwasaka 陈浩 《首都食品与医药》 2017年第2期80-80,共1页
(接2016年11月下) 尼可地尔组较对照组,其肌钙蛋白I水平在PCI治疗后24小时时显著降低(实验组及对照组分别为0.37±0.55和0.86±1.65ng/ml,P=0.0101),而CK水平也是在PCI治疗后24小时时显著降低(实验组及对照组分别为78.1&#... (接2016年11月下) 尼可地尔组较对照组,其肌钙蛋白I水平在PCI治疗后24小时时显著降低(实验组及对照组分别为0.37±0.55和0.86±1.65ng/ml,P=0.0101),而CK水平也是在PCI治疗后24小时时显著降低(实验组及对照组分别为78.1±34.9和117.4±137.9U/l,P=0.0141),CK-MB的水平变化也同前两者(实验组及对照组分别为1.57±1.90和2.67±4.50U/l,P=0.0485)。两组之间肌红蛋白水平的下降无显著差异。3.3 ST段位移所有患者在球囊扩展时均出现了ST段的抬高。 展开更多
关键词 尼可地尔 PCI 介入治疗 实验组 肌损伤 累计值 水平变化 心肌灌注 管腔直径 再狭窄发生率
原文传递
尼可地尔经皮冠状动脉介入治疗(PCI)降低心肌损伤
5
作者 Tsuyoshi Isono Hiroshi Kamihata +9 位作者 Yasuo Sutani Masayuki Motohiro Satoshi Yamamoto Shiori Kyoui Yoshiji Iharada Kouji Kurimoto Katsuko Hara Hakuo Takahashi toshiji iwasaka 陈浩 《首都食品与医药》 2016年第22期103-103,共1页
(接10月下)尼可地尔组26例患者推注4mg喜格迈(中外制药,东京,日本)后,以6mg/小时的速度持续静脉滴注尼可地尔24小时,之后口服此药物,剂量为每天15mg,直至PCI治疗3~6月后的冠状动脉造影(CAG)。对照组26例患者不使用尼可地尔。期间... (接10月下)尼可地尔组26例患者推注4mg喜格迈(中外制药,东京,日本)后,以6mg/小时的速度持续静脉滴注尼可地尔24小时,之后口服此药物,剂量为每天15mg,直至PCI治疗3~6月后的冠状动脉造影(CAG)。对照组26例患者不使用尼可地尔。期间3名患者按标准被排除,因此本研究中接收选择性PCI治疗的病例数实为49人(男性40例,女性9例;年龄为48~83岁;平均年龄为66±9岁)。所有患者将1.25~2.5mg硝酸异山梨酯(ISDN)注射入冠状动脉后,进行选择性PCI治疗。整个过程中对心率和血压进行持续的监测。 展开更多
关键词 尼可地尔 PCI 硝酸异山梨酯 持续静脉滴注 推注 肌损伤 心肌灌注 管腔直径 冠心病危险因素 肌钙蛋白
原文传递
尼可地尔经皮冠状动脉介入治疗(PCI)降低心肌损伤
6
作者 Tsuyoshi Isono Hiroshi Kamihata +9 位作者 Yasuo Sutani Masayuki Motohiro Satoshi Yamamoto Shiori Kyoui Yoshiji Iharada Kouji Kurimoto Katsuko Hara Hakuo Takahashi toshiji iwasaka 陈浩(译) 《首都食品与医药》 2017年第4期72-72,共1页
Tomai等人的研究表明在人体中,在主要反复心梗期间使用格列本脲这种选择性钾离子ATP通道抑制剂,会使缺血预适应完全失效。他们的研究结果表明缺血预适应可主要通过钾离子ATP通道来介导。特别是近期的研究结果表明,线粒体的钾离子ATP... Tomai等人的研究表明在人体中,在主要反复心梗期间使用格列本脲这种选择性钾离子ATP通道抑制剂,会使缺血预适应完全失效。他们的研究结果表明缺血预适应可主要通过钾离子ATP通道来介导。特别是近期的研究结果表明,线粒体的钾离子ATP通道较细胞表面的钾离子ATP通道在缺血预适应中发挥了更主要的作用。 展开更多
关键词 经皮冠状动脉介入治疗 心肌损伤 尼可地尔 缺血预适应 ATP 钾离子 格列本脲 细胞表面
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部